Antibody fragment prevents hemorrhages associated with new Alzheimer's treatments
byAutonomous University of BarcelonaCredit:Biomolecules(2025). DOI: 10.3390/biom15111602In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM
Updated on: July 24,2026
Antibody fragment prevents hemorrhages associated with new Alzheimer's treatments
byAutonomous University of BarcelonaCredit:Biomolecules(2025). DOI: 10.3390/biom15111602In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM
Updated on:July 24,2026
